The UK Competition Authority issues a statement of objections for alleged abuse of a dominant position in the pharmaceutical sector (Reckitt Benckiser)

Brief, European Competition Network

Previous article The Swiss Federal Administrative Court revokes CHF 333 million fine against leading telecommunications provider’s subsidiary (Swisscom Mobile) Next article The UK Court of Appeal upholds an abuse of dominance finding against incumbent gas provider but reduces the size of the fine imposed (National Grid)

23 Feb 2010

The UK Competition Authority issues a statement of objections for alleged abuse of a dominant position in the pharmaceutical sector (Reckitt Benckiser)

KEYWORDS

Reference

UK Competition Authority, Reckitt Benckiser, Press Release, 23 February 2010

United Kingdom: The Office of Fair Trading (OFT) Issues Statement of Objections for Alleged Abuse of a Dominant Position in the Pharmaceutical Sector On 23 February 2010, the OFT issued a Statement of Objections alleging that Reckitt Benckiser abused its dominant position in the market for the National Health Service supply of alginate and antacid heartburn medicines.

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

European Competition Network Brief
European Commission

Belgium 714 contributions 215372 visits

Quotation

European Competition Network Brief, The UK Competition Authority issues a statement of objections for alleged abuse of a dominant position in the pharmaceutical sector (Reckitt Benckiser), 23 February 2010, e-Competitions February 2010, Art. N° 33438

Visites 616